- Exchange: Berlin
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Snapshot for Lipid Sciences Inc (G6B)
| Open: | 0.002 | Day's Range: | 0.002 - 0.002 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.002 | 52wk Range: | 0.001 - 0.003 | 1-Yr Rtn: | +100.00% |
Key Statistics for G6B
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for G6B
No data available
Company Profile & Key Executives for G6B
Lipid Sciences, Inc. is a biotechnology company. The Company holds technology that selectively removes lipids such as cholesterol and triglycerides from lipoproteins and lipid-coated infectious agents. Lipid Sciences is currently clinical trial testing the ability of it's technology to reverse atherosclerosis in humans.
| H Bryan Brewer JrVice Chairman/Chief Sci Dir | S Lewis MeyerPresident/CEO |
| Jo-Ann MaltaisVP:Scientific Affairs | Dale L RichardsonVP:Business Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
G6B News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page